| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |